{"id":"otx-tki","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation"},{"rate":null,"effect":"Conjunctival hyperemia"},{"rate":null,"effect":"Eye discomfort"}]},"_chembl":{"chemblId":"CHEMBL522892","moleculeType":"Small molecule","molecularWeight":"392.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"OTX-TKI is a small-molecule tyrosine kinase inhibitor formulated for direct application to the eye surface. It targets multiple receptor tyrosine kinases involved in ocular inflammation and angiogenesis, with the goal of treating dry eye disease and other anterior segment conditions through sustained local delivery.","oneSentence":"OTX-TKI is a tyrosine kinase inhibitor designed for topical ocular delivery to treat eye surface diseases.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:53.844Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease"},{"name":"Ocular surface inflammation"}]},"trialDetails":[{"nctId":"NCT07235085","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy","status":"RECRUITING","sponsor":"Ocular Therapeutix, Inc.","startDate":"2025-11-17","conditions":"Non-Proliferative Diabetic Retinopathy","enrollment":930},{"nctId":"NCT06495918","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ocular Therapeutix, Inc.","startDate":"2024-11-27","conditions":"Neovascular Age-related Macular Degeneration","enrollment":825},{"nctId":"NCT06223958","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ocular Therapeutix, Inc.","startDate":"2024-01-29","conditions":"Neovascular Age-Related Macular Degeneration","enrollment":344},{"nctId":"NCT03630315","phase":"PHASE1","title":"CLN-0046: Treatment of AMD Subjects With OTX-TKI","status":"COMPLETED","sponsor":"Ocular Therapeutix, Inc.","startDate":"2019-02-18","conditions":"Neovascular Age-related Macular Degeneration","enrollment":29},{"nctId":"NCT04989699","phase":"PHASE1","title":"Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration","status":"COMPLETED","sponsor":"Ocular Therapeutix, Inc.","startDate":"2021-07-28","conditions":"Neovascular Age-Related Macular Degeneration","enrollment":21},{"nctId":"NCT05695417","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Ocular Therapeutix, Inc.","startDate":"2023-01-15","conditions":"Non-proliferative Diabetic Retinopathy","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"OTX-TKI","genericName":"OTX-TKI","companyName":"Ocular Therapeutix, Inc.","companyId":"ocular-therapeutix-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OTX-TKI is a small molecule inhibitor of fibroblast growth factor receptor 3, classified as a tyrosine kinase inhibitor. It is being studied in clinical trials for the treatment of Non-Proliferative Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}